BioSpace News Archive

Anthropogenic activities have led to increased amounts of mercury being discharged into aquatic systems, where it accumulates in fish as methylmercury, an organic form of mercury that is neurotoxic.

NEOGEN® Corporation and Gencove, the leading low-pass whole genome sequencing and analysis software company, announced the launch of InfiniSEEK™, an innovative, cost-effective solution for whole genome sequencing and targeted SNP analysis.

Clarus Therapeutics Holdings, Inc. (“Clarus”) (Nasdaq:CRXT), a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies for men and women, today announced it will release its first quarter 2022 financial and operating results on Monday, May 16, 2022, after the market closes.

Kineticos Life Sciences announced today that Thomas A. Pitler, Ph.D. has joined as President and Chief Operating Officer.

Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye”) and Emerald Health Therapeutics, Inc. (CSE: EMH; OTCQB: EMHTF) (“Emerald”) announced today that the companies have entered into a definitive agreement with respect to a transaction to be completed by way of a Plan of Arrangement (the “Arrangement”) whereby Skye would acquire all of the issued and outstanding shares of Emerald in a share-for-share-transaction.

Pulmatrix, Inc. (NASDAQ: PULM), a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSE™ technology, today announced first quarter financial results for 2022 and provided a corporate update.

SAB Biotherapeutics, announced its participation at the H.C. Wainwright Global Investment Conference, which takes place May 23-26, 2022.

SynerFuse™, Inc., a Minneapolis-based medical device company, is pleased to announce the addition of Steven M. Falowski, M.D., F.A.A.N.S., as a strategic advisor.

GE Healthcare has entered into an agreement to invest up to $50 million in Israeli start-up Pulsenmore, marking another strategic step forward in enabling precision health.

American Academy of Stem Cell Physicians will host expert speakers from across the country lecturing on the recent innovations in Stem Cell research on June 17-19, 2022 in Miami.